cis-4-Hydroxy-L-proline

cis-4-Hydroxy-L-proline is a chiral, cyclic amino acid featuring a pyrrolidine ring with a side-chain hydroxyl at the 4-position and an L-configured stereocenter on the ring. The molecule presents a secondary amine and a carboxylic acid functionality that can be selectively protected or activated for peptide coupling, while the hydroxyl group enables hydrogen-bonding interactions and further derivatization to ether, ester, or leaving-group variants. The cis relationship between the ring substituents constrains conformational preferences, which can influence amide bond geometry and downstream scaffold recognition in peptidomimetics and protein-contacting ligands. As an amino acid intermediate, cis-4-Hydroxy-L-proline can be incorporated into protected amino acid strategies or converted into activated derivatives for stereochemically defined synthetic sequences.

1. Peptide Synthesis

cis-4-Hydroxy-L-proline is applied in peptide building workflows where its carboxyl group can be activated for amide bond formation and its secondary amine can be protected to control coupling order. The 4-hydroxyl side chain participates in selective protection-group strategies, enabling orthogonal chemistry such as temporary O-protection during chain assembly followed by late-stage deprotection. The cis stereochemistry supports the construction of conformationally constrained peptide segments, including proline-rich motifs and hydroxyproline-containing analogs used to probe backbone effects. Downstream, the resulting hydroxyproline-containing peptides can serve as research-grade substrates for biochemical assays and as defined intermediates for peptidomimetic libraries.

2. Peptidomimetics Development

cis-4-Hydroxy-L-proline is utilized in peptidomimetic and constrained scaffold design where the ring-locked proline framework and cis hydroxyl substitution provide a defined three-dimensional presentation of hydrogen-bond donors/acceptors. The hydroxyl group can be converted into ethers or esters to tune polarity, metabolic stability, or receptor-contact geometry, while maintaining the stereochemical integrity of the L-center. The carboxyl functionality can be transformed into amide, ester, or other linkage types to generate analogs compatible with fragment-based molecular design and SAR studies. The resulting hydroxyproline-derived mimetics can then be advanced into structure-defined chemical probes and synthetic intermediates for medicinal chemistry campaigns.

3. Chemical Biology Probes

cis-4-Hydroxy-L-proline is relevant to chemical biology workflows that require stereochemically defined amino acid derivatives for biomolecular labeling and interaction studies. The side-chain hydroxyl enables conjugation strategies through O-functionalization routes, including formation of activated esters or clickable handles after suitable protection/deprotection planning. The amino acid backbone can be incorporated into peptide tags, affinity probes, or enzyme substrate analogs where conformational constraints from the cis ring substitution influence binding orientation. The produced labeled or modified biomolecule constructs can function as research tools for mapping recognition motifs, monitoring binding events, and generating defined standards for analytical characterization.

4. Protected Amino Acid Chemistry

cis-4-Hydroxy-L-proline is suitable for protected amino acid synthesis where selective control of the carboxyl group, secondary amine, and hydroxyl functionality is required for reliable peptide coupling chemistry. The presence of both an alcohol and a carboxylic acid supports orthogonal protection-group strategies that allow stepwise assembly, such as O-protection during N-activation and subsequent deprotection to expose the hydroxyl for later functionalization. The constrained proline ring stereochemistry helps maintain configurational fidelity through synthetic sequences that involve activation, coupling, and final deprotection. The resulting protected derivatives can serve as process-compatible intermediates for fine chemical synthesis and for manufacturing routes that prioritize reproducible stereochemical outcomes.

5. Pharmaceutical Intermediate Preparation

cis-4-Hydroxy-L-proline is employed as a chiral intermediate in the preparation of hydroxyproline-containing fragments used in pharmaceutical intermediate supply chains. The amino acid's functional group set enables conversion into activated building blocks for incorporation into larger heteroatom-rich scaffolds, including amide-linked motifs and hydroxyl-bearing side chains that influence solubility and intermolecular interactions. The cis stereochemistry and L-configuration provide a defined stereochemical element that can be carried into downstream synthetic steps, including late-stage coupling to complex molecules. The compound can therefore support industrial fine chemical synthesis and specialty chemical production where stereodefined amino acid units are required for consistent downstream elaboration.

6. Process Chemistry And Fine Synthesis

cis-4-Hydroxy-L-proline is applicable to process chemistry and fine chemical synthesis as a chiral feedstock for generating functionalized amino acid derivatives under controlled protection-group and activation schemes. The secondary amine and carboxylic acid enable formation of intermediates such as activated acids, amide-linked derivatives, or esterified intermediates, while the hydroxyl group can be selectively transformed to modulate reactivity and downstream handling. The cis ring substitution can reduce conformational ambiguity in intermediates, which may improve reproducibility when translating amino acid chemistry into scalable manufacturing sequences. The resulting derivative stream can feed into peptide building block preparation, peptidomimetic fragment manufacture, and analytical standard development for stereochemically defined research materials.

1. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

2. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

3. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active

4. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

5. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII